Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fellay

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Revue Medicale Suisse|May 6, 2006
[HIV-AIDS: answers to new questions]J Fellay, M Cavassini
Transplantation Proceedings|April 26, 2005
Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovirJ Fellay, J-P Venetz, J-D Aubert, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 13, 2015
Opportunistic testing for urogenital infection with Chlamydia trachomatis in south-western Switzerland, 2012: a feasibility studyF Bally, A Quach, G Greub, et al.
HIV Medicine|April 17, 2012
HLA-Bw4 identifies a population of HIV-infected patients with an increased capacity to control viral replication after structured treatment interruptionM Stern, K Czaja, A Rauch, et al.
Lancet (London, England)|October 31, 2001
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort StudyJ Fellay, K Boubaker, B Ledergerber, et al.
Virus Evolution|September 17, 2021
Human genomics of the humoral immune response against polyomavirusesF Hodel, A Y Chong, P Scepanovic, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2019
Gender medicine and oncology: report and consensus of an ESMO workshopA D Wagner, S Oertelt-Prigione, A Adjei, et al.
Journal of Viral Hepatitis|April 14, 2012
Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment responseP J Clark, A J Thompson, M Zhu, et al.
Open Forum Infectious Diseases|March 4, 2015
Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort StudyBarbara Hasse, Martin Iff, Bruno Ledergerber, et al.
Open Forum Infectious Diseases|July 17, 2015
Increases in Condomless Sex in the Swiss HIV Cohort StudyRoger D Kouyos, Barbara Hasse, Alexandra Calmy, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Revue Medicale Suisse|May 6, 2006
[HIV-AIDS: answers to new questions]J Fellay, M Cavassini
Transplantation Proceedings|April 26, 2005
Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovirJ Fellay, J-P Venetz, J-D Aubert, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 13, 2015
Opportunistic testing for urogenital infection with Chlamydia trachomatis in south-western Switzerland, 2012: a feasibility studyF Bally, A Quach, G Greub, et al.
HIV Medicine|April 17, 2012
HLA-Bw4 identifies a population of HIV-infected patients with an increased capacity to control viral replication after structured treatment interruptionM Stern, K Czaja, A Rauch, et al.
Lancet (London, England)|October 31, 2001
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort StudyJ Fellay, K Boubaker, B Ledergerber, et al.
Virus Evolution|September 17, 2021
Human genomics of the humoral immune response against polyomavirusesF Hodel, A Y Chong, P Scepanovic, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2019
Gender medicine and oncology: report and consensus of an ESMO workshopA D Wagner, S Oertelt-Prigione, A Adjei, et al.
Journal of Viral Hepatitis|April 14, 2012
Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment responseP J Clark, A J Thompson, M Zhu, et al.
Open Forum Infectious Diseases|March 4, 2015
Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort StudyBarbara Hasse, Martin Iff, Bruno Ledergerber, et al.
Open Forum Infectious Diseases|July 17, 2015
Increases in Condomless Sex in the Swiss HIV Cohort StudyRoger D Kouyos, Barbara Hasse, Alexandra Calmy, et al.
Pageof 2